Non-face-to-face Medical Platform 'Ollacare' Surpasses 1 Million Cumulative Downloads

[Asia Economy Reporter Lee Gwan-joo] 'Ollacare,' a non-face-to-face medical consultation and medicine delivery platform operated by BlueAnt, surpassed 1 million cumulative downloads just seven months after its service launch.

Ollacare announced on the 2nd that as of last month, the app's cumulative downloads, app users, and cumulative medical consultations each exceeded 1 million, 1.5 million, respectively. In particular, the monthly active users (MAU) reached 510,000, showing more than threefold growth compared to the previous month over the past month.

According to Ollacare's cumulative user analysis data, the most frequently treated conditions were general other diseases (24%), respiratory diseases (21%), and home treatment (17%) in that order. Home treatment accounted for a high proportion of consultations in a short time since its recent implementation. Additionally, among all users, women in their 30s and 40s accounted for 32%, followed by men in their 40s and 50s at 20%. Compared to the early service period when women in their 20s and 30s had a high usage rate, the user base of the non-face-to-face medical consultation platform has expanded to various age groups. This is analyzed to be due to the recent surge in interest in non-face-to-face medical consultations caused by home treatment.

On the 10th of last month, Ollacare established the industry's first 'dedicated home treatment service' in line with the government's transition to COVID-19 home treatment. When classified as a general management group for home treatment after a COVID-19 diagnosis, users can click the home treatment tab in the Ollacare app to connect with hospitals registered as respiratory clinics. Medical consultation fees and prescription fees are free of charge, and nationwide medicine delivery fees are also supported free of charge. In response to the rapidly increasing demand for consultations due to recent home treatment, Ollacare is making every effort, including increasing partner hospitals and medicine delivery personnel.

The growth of Ollacare is supported by BlueAnt's hospital and clinic insurance reimbursement review solution ‘Rx+’ and the doctor community ‘Docple.’ With the experience and capabilities of operating Rx+, used by 1,500 hospitals and clinics nationwide, and the representative doctor community Docple, a path was opened for local clinics to quickly join the platform to conduct non-face-to-face medical consultations.

Kim Seong-hyun, CEO of BlueAnt, said, "During the process of establishing the dedicated home treatment service, I believe that the services operated by BlueAnt created synergy and were able to provide differentiated services." He added, "We will quickly improve user inconveniences and do our best to ensure that non-face-to-face medical consultations settle in the market through more active communication with related parties such as medical and pharmaceutical associations."

This content was produced with the assistance of AI translation services.